Chemoinformaics analysis of 1-o-feruloyl-beta-d-glucose
| Molecular Weight | 226.316 | nRot | 6 |
| Heavy Atom Molecular Weight | 204.14 | nRig | 16 |
| Exact Molecular Weight | 226.157 | nRing | 1 |
| Solubility: LogS | -4.004 | nHRing | 0 |
| Solubility: LogP | 2.437 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 38.7854 |
| nHD | 0 | BPOL | 25.5426 |
| QED | 0.643 |
| Synth | 2.457 |
| Natural Product Likeliness | 0.616 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.148 |
| HIA | 0.009 |
| CACO-2 | -4.774 |
| MDCK | 0.0000295 |
| BBB | 0.861 |
| PPB | 0.878946 |
| VDSS | 0.613 |
| FU | 0.0872556 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.948 |
| CYP2c19-inh | 0.9 |
| CYP2c19-sub | 0.496 |
| CYP2c9-inh | 0.477 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.745 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.396 |
| CYP3a4-sub | 0.291 |
| CL | 4.651 |
| T12 | 0.32 |
| hERG | 0.055 |
| Ames | 0.894 |
| ROA | 0.133 |
| SkinSen | 0.15 |
| Carcinogencity | 0.93 |
| EI | 0.859 |
| Respiratory | 0.908 |
| NR-Aromatase | 0.083 |
| Antiviral | Yes |
| Prediction | 0.767426 |